Economic information and modeling reportBudget impact model
Perspective and time frame
2 evidence topics · 4 sources
Budget impact model of ficerafusp alfa: perspective and time frame
No evidence found.
Perspective recommended for budget impact analysis
Perspectives and time horizons of United States cost-effectiveness analyses of first-line regimens
“A three-state partitioned-survival model was used to project costs and outcomes over 20 years with 3% annual discounting.” (opens the original PubMed page at this quote in a new tab)View highlighted excerpt for this quote
“The purpose of this study was to compare the cost-effectiveness of nivolumab plus ipilimumab with EXTREME in the first-line setting from the standpoint of third-party payers in the United States.” (opens the original PMC page at this quote in a new tab)View highlighted excerpt for this quote
“The projecting of costs and outcomes over 15 years was done using a three-state partitioned survival model discounted by 3% per year.” (opens the original PMC page at this quote in a new tab)View highlighted excerpt for this quote
“The time horizon was 15 years given that more than 98% of the cohort died.” (opens the original PMC page at this quote in a new tab)View highlighted excerpt for this quote